Acute Bacterial Exacerbation of Chronic Bronchitis Completed Phase 3 Trials for Clarithromycin (DB01211)

Also known as: Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) / Bronchitis bacterial / Septic bronchitis (disorder) / Bronchitis bacterial NOS

IndicationStatusPhase
DBCOND0053867 (Acute Bacterial Exacerbation of Chronic Bronchitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00645086
Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic BronchitisTreatment